SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression

Wenjian Gan, Xiangpeng Dai, Andrea Lunardi, Zhen Li, Hiroyuki Inuzuka, Pengda Liu, Shoreh Varmeh, Jinfang Zhang, Liang Cheng, Yin Sun, John M. Asara, Andrew H. Beck, Jiaoti Huang, Pier Paolo Pandolfi, Wenyi Wei

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The ERG gene is fused to TMPRSS2 in approximately 50% of prostate cancers (PrCa), resulting in its overexpression. However, whether this is the sole mechanism underlying ERG elevation in PrCa is currently unclear. Here we report that ERG ubiquitination and degradation are governed by the Cullin 3-based ubiquitin ligase SPOP and that deficiency in this pathway leads to aberrant elevation of the ERG oncoprotein. Specifically, we find that truncated ERG (δERG), encoded by the ERG fusion gene, is stabilized by evading SPOP-mediated destruction, whereas prostate cancer-associated SPOP mutants are also deficient in promoting ERG ubiquitination. Furthermore, we show that the SPOP/ERG interaction is modulated by CKI-mediated phosphorylation. Importantly, we demonstrate that DNA damage drugs, topoisomerase inhibitors, can trigger CKI activation to restore the SPOP/δERG interaction and its consequent degradation. Therefore, SPOP functions as a tumor suppressor to negatively regulate the stability of the ERG oncoprotein in prostate cancer. Gan et al. report that the Cullin 3<sup>SPOP</sup> E3 ubiquitin ligase plays a critical tumor-suppressive role in prostate cancer by negatively controlling ERG stability. Therefore, either SPOP mutation or ERG fusion can lead to elevated ERG protein levels by evading the SPOP-mediated degradation pathway to promote prostate cancer progression.

Original languageEnglish
Pages (from-to)917-930
Number of pages14
JournalMolecular Cell
Volume59
Issue number6
DOIs
StatePublished - Sep 17 2015

Fingerprint

Ubiquitination
Oncogene Proteins
Prostatic Neoplasms
Cullin Proteins
Topoisomerase Inhibitors
Ubiquitin-Protein Ligases
Gene Fusion
Ligases
Ubiquitin
DNA Damage
Neoplasms
Phosphorylation
Mutation
Pharmaceutical Preparations
Genes
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. / Gan, Wenjian; Dai, Xiangpeng; Lunardi, Andrea; Li, Zhen; Inuzuka, Hiroyuki; Liu, Pengda; Varmeh, Shoreh; Zhang, Jinfang; Cheng, Liang; Sun, Yin; Asara, John M.; Beck, Andrew H.; Huang, Jiaoti; Pandolfi, Pier Paolo; Wei, Wenyi.

In: Molecular Cell, Vol. 59, No. 6, 17.09.2015, p. 917-930.

Research output: Contribution to journalArticle

Gan, W, Dai, X, Lunardi, A, Li, Z, Inuzuka, H, Liu, P, Varmeh, S, Zhang, J, Cheng, L, Sun, Y, Asara, JM, Beck, AH, Huang, J, Pandolfi, PP & Wei, W 2015, 'SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression', Molecular Cell, vol. 59, no. 6, pp. 917-930. https://doi.org/10.1016/j.molcel.2015.07.026
Gan, Wenjian ; Dai, Xiangpeng ; Lunardi, Andrea ; Li, Zhen ; Inuzuka, Hiroyuki ; Liu, Pengda ; Varmeh, Shoreh ; Zhang, Jinfang ; Cheng, Liang ; Sun, Yin ; Asara, John M. ; Beck, Andrew H. ; Huang, Jiaoti ; Pandolfi, Pier Paolo ; Wei, Wenyi. / SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. In: Molecular Cell. 2015 ; Vol. 59, No. 6. pp. 917-930.
@article{8717e5c2fac84198ab5964f1e9d43e9a,
title = "SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression",
abstract = "The ERG gene is fused to TMPRSS2 in approximately 50{\%} of prostate cancers (PrCa), resulting in its overexpression. However, whether this is the sole mechanism underlying ERG elevation in PrCa is currently unclear. Here we report that ERG ubiquitination and degradation are governed by the Cullin 3-based ubiquitin ligase SPOP and that deficiency in this pathway leads to aberrant elevation of the ERG oncoprotein. Specifically, we find that truncated ERG (δERG), encoded by the ERG fusion gene, is stabilized by evading SPOP-mediated destruction, whereas prostate cancer-associated SPOP mutants are also deficient in promoting ERG ubiquitination. Furthermore, we show that the SPOP/ERG interaction is modulated by CKI-mediated phosphorylation. Importantly, we demonstrate that DNA damage drugs, topoisomerase inhibitors, can trigger CKI activation to restore the SPOP/δERG interaction and its consequent degradation. Therefore, SPOP functions as a tumor suppressor to negatively regulate the stability of the ERG oncoprotein in prostate cancer. Gan et al. report that the Cullin 3SPOP E3 ubiquitin ligase plays a critical tumor-suppressive role in prostate cancer by negatively controlling ERG stability. Therefore, either SPOP mutation or ERG fusion can lead to elevated ERG protein levels by evading the SPOP-mediated degradation pathway to promote prostate cancer progression.",
author = "Wenjian Gan and Xiangpeng Dai and Andrea Lunardi and Zhen Li and Hiroyuki Inuzuka and Pengda Liu and Shoreh Varmeh and Jinfang Zhang and Liang Cheng and Yin Sun and Asara, {John M.} and Beck, {Andrew H.} and Jiaoti Huang and Pandolfi, {Pier Paolo} and Wenyi Wei",
year = "2015",
month = "9",
day = "17",
doi = "10.1016/j.molcel.2015.07.026",
language = "English",
volume = "59",
pages = "917--930",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression

AU - Gan, Wenjian

AU - Dai, Xiangpeng

AU - Lunardi, Andrea

AU - Li, Zhen

AU - Inuzuka, Hiroyuki

AU - Liu, Pengda

AU - Varmeh, Shoreh

AU - Zhang, Jinfang

AU - Cheng, Liang

AU - Sun, Yin

AU - Asara, John M.

AU - Beck, Andrew H.

AU - Huang, Jiaoti

AU - Pandolfi, Pier Paolo

AU - Wei, Wenyi

PY - 2015/9/17

Y1 - 2015/9/17

N2 - The ERG gene is fused to TMPRSS2 in approximately 50% of prostate cancers (PrCa), resulting in its overexpression. However, whether this is the sole mechanism underlying ERG elevation in PrCa is currently unclear. Here we report that ERG ubiquitination and degradation are governed by the Cullin 3-based ubiquitin ligase SPOP and that deficiency in this pathway leads to aberrant elevation of the ERG oncoprotein. Specifically, we find that truncated ERG (δERG), encoded by the ERG fusion gene, is stabilized by evading SPOP-mediated destruction, whereas prostate cancer-associated SPOP mutants are also deficient in promoting ERG ubiquitination. Furthermore, we show that the SPOP/ERG interaction is modulated by CKI-mediated phosphorylation. Importantly, we demonstrate that DNA damage drugs, topoisomerase inhibitors, can trigger CKI activation to restore the SPOP/δERG interaction and its consequent degradation. Therefore, SPOP functions as a tumor suppressor to negatively regulate the stability of the ERG oncoprotein in prostate cancer. Gan et al. report that the Cullin 3SPOP E3 ubiquitin ligase plays a critical tumor-suppressive role in prostate cancer by negatively controlling ERG stability. Therefore, either SPOP mutation or ERG fusion can lead to elevated ERG protein levels by evading the SPOP-mediated degradation pathway to promote prostate cancer progression.

AB - The ERG gene is fused to TMPRSS2 in approximately 50% of prostate cancers (PrCa), resulting in its overexpression. However, whether this is the sole mechanism underlying ERG elevation in PrCa is currently unclear. Here we report that ERG ubiquitination and degradation are governed by the Cullin 3-based ubiquitin ligase SPOP and that deficiency in this pathway leads to aberrant elevation of the ERG oncoprotein. Specifically, we find that truncated ERG (δERG), encoded by the ERG fusion gene, is stabilized by evading SPOP-mediated destruction, whereas prostate cancer-associated SPOP mutants are also deficient in promoting ERG ubiquitination. Furthermore, we show that the SPOP/ERG interaction is modulated by CKI-mediated phosphorylation. Importantly, we demonstrate that DNA damage drugs, topoisomerase inhibitors, can trigger CKI activation to restore the SPOP/δERG interaction and its consequent degradation. Therefore, SPOP functions as a tumor suppressor to negatively regulate the stability of the ERG oncoprotein in prostate cancer. Gan et al. report that the Cullin 3SPOP E3 ubiquitin ligase plays a critical tumor-suppressive role in prostate cancer by negatively controlling ERG stability. Therefore, either SPOP mutation or ERG fusion can lead to elevated ERG protein levels by evading the SPOP-mediated degradation pathway to promote prostate cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84941752941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941752941&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2015.07.026

DO - 10.1016/j.molcel.2015.07.026

M3 - Article

VL - 59

SP - 917

EP - 930

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 6

ER -